Quarterly report · Q1
7747.TEDINET S100PL3Y
Period2022-07-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥22.7bn | 2022-07-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥77.7bn | 2021-07-01 → 2022-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥18.1bn | 2021-07-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥4.7bn | 2022-07-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥3.8bn | 2021-07-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥5.0bn | 2022-07-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥16.3bn | 2021-07-01 → 2022-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.8bn | 2021-07-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥5.2bn | 2022-07-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥4.4bn | 2021-07-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥4.0bn | 2022-07-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥10.9bn | 2021-07-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.3bn | 2021-07-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥4.1bn | 2022-07-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥3.4bn | 2021-07-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥154.8bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥155.1bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥136.1bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥32.3bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥34.0bn | at 2022-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥122.5bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥121.1bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥106.9bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥27.4bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥32.3bn | at 2022-06-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥14.91 | 2022-07-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥40.01 | 2021-07-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.31 | 2021-07-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥40 | 2021-07-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥12.3 | 2021-07-01 → 2021-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 78.0% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.0% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.5% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2022-09-30 | −¥4.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2022-09-30 | −¥4.1bn |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2022-09-30 | −¥1.2bn |
| jpcrp040300-q1r_E02349-000Devicereportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥7.0bn |
| jpcrp040300-q1r_E02349-000Devicereportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥2.9bn |
| jpcrp040300-q1r_E02349-000Devicereportable segment | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥4.1bn |
| jpcrp040300-q1r_E02349-000Devicereportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q1r_E02349-000Medicalreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥19.7bn |
| jpcrp040300-q1r_E02349-000Medicalreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥19.7bn |
| jpcrp040300-q1r_E02349-000Medicalreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥4.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-07-01 → 2022-09-30 | ¥26.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-07-01 → 2022-09-30 | ¥22.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥4.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-07-01 → 2022-09-30 | ¥5.8bn |
| Reconciling Itemsreconciling | revenue | 2021-07-01 → 2021-09-30 | −¥3.0bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-07-01 → 2021-09-30 | −¥3.0bn |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2021-09-30 | −¥995m |
| jpcrp040300-q1r_E02349-000Devicereportable segment | revenue | 2021-07-01 → 2021-09-30 | ¥5.2bn |
| jpcrp040300-q1r_E02349-000Devicereportable segment | revenue external | 2021-07-01 → 2021-09-30 | ¥2.2bn |
| jpcrp040300-q1r_E02349-000Devicereportable segment | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥3.0bn |
| jpcrp040300-q1r_E02349-000Devicereportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥1.2bn |
| jpcrp040300-q1r_E02349-000Medicalreportable segment | revenue | 2021-07-01 → 2021-09-30 | ¥15.9bn |
| jpcrp040300-q1r_E02349-000Medicalreportable segment | revenue external | 2021-07-01 → 2021-09-30 | ¥15.9bn |
| jpcrp040300-q1r_E02349-000Medicalreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥3.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-07-01 → 2021-09-30 | ¥21.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-07-01 → 2021-09-30 | ¥18.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥3.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-07-01 → 2021-09-30 | ¥4.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 340
| Item | Context | Value | Unit |
|---|---|---|---|
| Other comprehensive income | Prior1YTDDuration | -199000000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 502000000 | JPY |
| Comprehensive income | Prior1YTDDuration | 3169000000 | JPY |
| Comprehensive income | CurrentYTDDuration | 4591000000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 3134000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 4552000000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | 35000000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | 39000000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -86000000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentQuarterInstant | -85000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E02349-000MedicalReportableSegmentsMember | 15903000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E02349-000DeviceReportableSegmentsMember | 2217000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 18120000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 18120000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E02349-000MedicalReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E02349-000DeviceReportableSegmentsMember | 2964000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 2964000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -2964000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E02349-000MedicalReportableSegmentsMember | 15903000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E02349-000DeviceReportableSegmentsMember | 5182000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 21085000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -2964000000 | JPY |
| Net sales | Prior1YTDDuration | 18120000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E02349-000MedicalReportableSegmentsMember | 3557000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E02349-000DeviceReportableSegmentsMember | 1198000000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 4755000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -995000000 | JPY |
| Operating income | Prior1YTDDuration | 3759000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E02349-000MedicalReportableSegmentsMember | 19736000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E02349-000DeviceReportableSegmentsMember | 2921000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 22658000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 22658000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E02349-000MedicalReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E02349-000DeviceReportableSegmentsMember | 4076000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 4076000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -4076000000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E02349-000MedicalReportableSegmentsMember | 19736000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E02349-000DeviceReportableSegmentsMember | 6998000000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 26735000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -4076000000 | JPY |
| Net sales | CurrentYTDDuration | 22658000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E02349-000MedicalReportableSegmentsMember | 4006000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E02349-000DeviceReportableSegmentsMember | 1842000000 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 5848000000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -1162000000 | JPY |
| Operating income | CurrentYTDDuration | 4686000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |